Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

In Vivo Brain MR Imaging at Subnanoliter Resolution: Contrast and Histology.
Four Square Step Test in ambulant persons with multiple sclerosis: validity, reliability, and responsiveness.
Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndrome.
Safety and efficacy extension study of daclizumab high yield process (DAC HYP) to treat relapsing remitting multiple sclerosis
Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden.
[Sexuality of men with neurologic disorders].
Subcutaneous interferon β-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective study.
The autonomic balance predicts cardiac responses after the first dose of fingolimod.
Mesenchymal stem cells as treatment for MS - progress to date.
A case of multiple sclerosis improvement following removal of heavy metal intoxication : Lessons learnt from Matteo's case.
Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis.
Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease.
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.
Severe septal panniculitis in a multiple sclerosis patient treated with interferon-beta.
Importance of Rookshana Karma (dehydrating therapy) in the management of transverse myelitis.
Alemtuzumab 3-year data show durable effect on MS disability
Multiple sclerosis and stress.
In Active Relapsing-Remitting Multiple Sclerosis, Effector T Cell Resistance to Adaptive Tregs Involves IL-6-Mediated Signaling.
Birth outcomes of pregnancies fathered by men with multiple sclerosis.
Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk.
Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.
Update on the Autoimmune Pathology of Multiple Sclerosis: B-Cells as Disease-Drivers and Therapeutic Targets.
MiR-30a inhibits Th17 differentiation and demyelination of EAE mice by targeting the IL-21R.
Impact of diagnosis and early treatment on the course of multiple sclerosis.
Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology.

Pages